| ID | Name | CAS | Data |
Inp |
| 34-097-7 |
Isonipecotinoylisonipecotic acid, N'-(2,5-di(trifluoromethyl)benzoyl)-, propyl ester
|
|
3 | 3186.00 |
| 34-583-7 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, hexyl ester
|
|
3 | 2706.00 |
| 34-606-1 |
N-(2,2,3,3,4,4,4-Heptafluorobutanoyl)-N-(4-methoxy-1,3-benzothiazol-2-yl)-2,2,3,3,4,4,4-heptafluorobutanamide
|
|
3 | 1958.00 |
| 34-609-8 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 7-methyl
|
|
3 | 1696.00 |
| 34-872-6 |
Methyl 5-«beta»-cholan-3-«beta»-ol-12-one-24-oate, oxime, TMS
|
|
3 | 3201.00 |
| 35-400-8 |
5«beta»-Campestanol (24«alpha»-methyl-5«beta»-cholestan-3«beta»-ol), TMS
|
|
3 | 3107.00 |
| 35-819-4 |
5-methylaceto-5'-(3-buten-1-ynil)-2,2'-bithienyl
|
|
3 | 2373.00 |
| 35-938-2 |
5«alpha»-Pregnane-3«beta», 20«beta», 21-triol, MO TMS
|
|
3 | 3136.00 |
| 36-159-6 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, decyl ester
|
|
3 | 3155.00 |
| 36-250-4 |
epi-5«beta»-Campestanol (24«alpha»-methyl-5«beta»-cholestan-3«alpha»-ol), TMS
|
|
3 | 3113.00 |
| 36-417-9 |
O-Ethyl-O-(1,1-difluoro-2-bromoethyl)-N-(1-methylpropyl)-phosphorothioamidate
|
|
3 | [1451.00; 1545.00] |
| 36-761-7 |
5-Pregnen-3-«alpha»,20-«alpha»-diol-20-GlcNAc TMS
|
|
3 | 4383.00 |
| 36-920-0 |
2,5,5-Trimethyl-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 1140.00 |
| 36-921-9 |
2-Pyrrolidinone, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-
|
309-29-5 |
3 | [2860.00; 2906.00] |
| 37-009-1 |
3«alpha»,7«alpha»-dihydroxy-5«beta»-C27-bile acid, methyl ester, TMS
|
|
3 | 3452.00 |
| 37-178-4 |
1,3-Dimethyl-5-(3-hydroxycyclohexen-1-yl)hexahydropyrimidine-2,4,6-trione
|
|
3 | 2015.00 |
| 37-265-7 |
allo-Cholanic acid, 3«alpha»,7«alpha»,12«alpha»-trihydroxy, Me-DMES
|
|
3 | 3544.00 |
| 37-388-1 |
4-Cyclopropyl-6-methyl-N-acetyl-N-phenylpyrimidin-2-amine
|
|
3 | 2178.00 |
| 37-448-4 |
1-«beta»,3-«alpha»,12-«alpha»-Trihydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
3 | 3296.00 |
| 37-683-3 |
5-«beta»-Pregnan-3-«alpha»-ol-20-one, MO-TMS
|
|
3 | 2658.00 |
| 37-942-5 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, pentadecyl ester
|
|
3 | 3266.00 |
| 38-104-4 |
2-(N-Ethyl-N-m-tolyl)aminoethanol, (3-cyanopropyl)dimethylsilyl ether
|
|
3 | 2163.00 |
| 38-108-0 |
D-Tryptophan, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
3 | 2656.00 |
| 38-174-7 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,6-dimethyl-7,7-tetramethylene
|
|
3 | 1853.00 |
| 38-214-2 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, undecyl ester
|
|
3 | 3257.00 |
| 38-420-3 |
Silane, [(3,7,11,15-tetramethyl-2-hexadecenyl)oxy]trimethyl-
|
57397-39-4 |
3 | [2162.50; 2183.00] |
| 38-562-6 |
Androstane, 3,17-bis[(trimethylsilyl)oxy]-, (3«alpha»,5«alpha»,17«alpha»)-
|
10426-35-4 |
3 | [2464.00; 2489.00] |
| 38-659-9 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N-propyl-phosphorothioamidate
|
|
3 | 1435.00 |
| 38-861-4 |
5-«alpha»-Pregnan-3-«beta»-16-«alpha»-diol-20-one, TMS
|
|
3 | 2856.00 |
| 39-307-8 |
15,16-Epoxylabda-13(16),14-dien-8 .alpha.-ol
|
|
3 | 2211.00 |
| 39-432-9 |
Isonipecotinoylisonipecotic acid, N'-(2,5-di(trifluoromethyl)benzoyl)-, ethyl ester
|
|
3 | 3082.00 |
| 39-634-5 |
5-«alpha»-Pregnan-20-«beta»-ol-3-one, MO-TMS
|
|
3 | 2807.00 |
| 39-730-8 |
5-«beta»-Pregnan-20-«beta»-ol-3-one, MO-TMS
|
|
3 | 2757.00 |
| 39-739-9 |
2-Methyl-5-(fur-3-yl)-pent-1-en-3-ol
|
|
3 | 1252.00 |
| 39-949-6 |
2,4-Imidazolidinedione, 5,5-diphenyl-1,3-bis(trimethylsilyl)-
|
|
3 | 2272.90 |
| 40-056-5 |
6H-Pyrido[2,1-b]quinazolin-6-one, 7,8,9,10-tetrahydro- 9-methyl
|
|
3 | 2123.00 |
| 40-865-7 |
Pyrazolo[1,5-d][1,2,4]triazin-3-one, 2,5,6-trimethyl-7,7-tetramethylene
|
|
3 | 1807.00 |
| 41-014-0 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, propyl ester
|
|
3 | 2428.00 |
| 41-301-1 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, tridecyl ester
|
|
3 | 3457.00 |
| 41-340-8 |
1H-2,5-Benzoxazocine, 3,4,5,6-tetrahydro-5-methyl-1-phenyl-
|
|
3 | 2017.00 |
| 41-410-0 |
allo-Cholanic acid, 3«beta»,7«beta»,12«beta»-trihydroxy, Me-TMS
|
|
3 | 3429.00 |
| 41-507-3 |
2-(2,6-Dioxo-3-piperidyl)isoindoline-1,3-dione, N-trimethylsilyl-
|
|
3 | 2485.00 |
| 41-600-9 |
2,3,4,5,7,8,9,10,11,12-Decahydro-1H-5a,13-diaza-cyclohepta[4,5]benzo[1,2]cycloocten-6-one
|
|
3 | 2226.00 |
| 41-865-6 |
5-«alpha»-Pregnan-3-«beta»,20-«alpha»,21-triol, TMS
|
|
3 | 3091.00 |
| 42-134-6 |
1,2,3,4,6,7,8,9,10,11-Decahydro-5,11a-diaza-cycloocta[b]naphthalen-12-one
|
|
3 | 2165.00 |
| 42-582-9 |
5«beta»-Androstan-3«alpha»,11«beta»-diol-17-one (Androsterone), MO-3-mono-TMS
|
|
3 | 2618.00 |
| 42-635-0 |
5«beta»-Pregnane-3«beta»-ol-20-one, MO TMS
|
|
3 | 2737.00 |
| 42-657-6 |
2,6-Pyridinedicarboxylic acid, di(1-methoxydec-4-yl) ester
|
|
3 | 3157.00 |
| 42-702-5 |
2,6-Pyridinedicarboxylic acid, di(5-methoxy-3-methylpent-2-yl) ester
|
|
3 | 2606.00 |
| 43-278-6 |
6-methyl-1,2,3,4,5,6-hexahydro-(7H)-cyclopentapyridine-7-one
|
|
3 | 1457.00 |
| 43-416-2 |
3-[((1,1,3,3,5,5-Hexamethyl-5-[(3Z)-non-3-en-1-yloxy]trisiloxanyl)oxy)methyl]pyridine
|
|
3 | 2295.20 |
| 43-471-1 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 2,9-dimethyl
|
|
3 | 1714.00 |
| 43-527-9 |
3«alpha»,4«beta»,12«alpha»-trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
3 | 3400.00 |
| 43-713-2 |
Methyl 5-«beta»-cholan-3-«alpha»-ol-12-one-24-oate, oxime, TMS
|
|
3 | 3204.00 |
| 43-838-4 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 7-methyl
|
|
3 | 1654.00 |
| 43-987-9 |
N-(5-Methylisoxazol-3-yl)-N-(trifluoroacetyl)-2,2,2-trifluoroacetamide
|
|
3 | 964.00 |
| 44-184-9 |
Silanamine, 1,1,1-trimethyl-N-[2-[4-[(trimethylsilyl)oxy]phenyl]ethyl]-
|
54965-31-0 |
3 | [1630.00; 1653.00] |
| 44-200-0 |
N2-Cyclopropyl-1,3,5-triazine-2,4,6-triamine N6-acetyl
|
|
3 | 2152.00 |
| 44-271-2 |
(E)-1-(4-Methylphenyl)butan-1-one O-(tert-butyldimethylsilyl)oxime
|
|
3 | 1774.00 |
| 44-636-7 |
allo-Cholanic acid, 3«alpha»,7«beta»,12«beta»-trihydroxy, Me-DMES
|
|
3 | 3587.00 |
| 44-732-0 |
O-Methyl-O-(1,1-difluoro-2-bromoethyl)-N-allyl-phosphorothioamidate
|
|
3 | 1447.00 |
| 44-752-8 |
Pyrazolo[1,5-d][1,2,4]triazin-3-one, 2,5,6-trimethyl-7,7-pentamethylene
|
|
3 | 1939.00 |
| 44-863-5 |
Silane, [(3.beta.,5.alpha.)-cholest-7-en-3-yloxy]trimethyl-
|
|
3 | 3195.00 |
| 44-930-0 |
O-Methyl-O-(1,1-difluoro-2-bromoethyl)-N-isopropyl-phosphorothioamidate
|
|
3 | 1398.00 |
| 45-191-0 |
O-Ethyl-O-isobutyl-S-(1,1-difluoro-3-ethylheptyl)-dithiophosphate
|
|
3 | 1846.00 |
| 45-247-8 |
Silane, trimethyl[[(3«beta»,5«alpha»)-stigmastan-3-yl]oxy]-
|
55493-85-1 |
3 | [3343.00; 3349.00] |
| 45-316-1 |
Ethyl ([1,1,3,3-tetramethyl-3-(pyridin-3-ylmethoxy)disiloxanyl]oxy)acetate
|
|
3 | 1895.00 |
| 45-414-2 |
3«beta»,16«alpha»-dihydroxy-5«alpha»-androstan-17-one, TMS
|
|
3 | [2665.00; 2714.00] |
| 45-460-1 |
3-Amino-2,3-dihydrobenzoic acid, N-dimethylaminomethylene-, methyl ester
|
|
3 | 1685.00 |
| 45-501-5 |
O-Methyl-O-(1,1-difluoro-2-bromoethyl)-N-metyl-phosphorothioamidate
|
|
3 | 1339.00 |
| 45-604-1 |
7«alpha»-hydroxy, 3-oxy-4-cholenoate, methyl ester-trimethylsilyl ether
|
|
3 | 3300.00 |
| 45-797-8 |
3«beta»,4«beta»,12«alpha»-trihydroxy-5«beta»-cholanoic acid acid, methyl ester-trimethylsilyl-ether derivative
|
|
3 | 3303.00 |
| 45-936-3 |
3«beta»,16«alpha»-dihydroxy-5-androsten-17-one, MO-TMS, (syn,anti)
|
|
3 | [2679.00; 2728.00] |
| 46-049-7 |
11H-Pyrido[2,1-b]quinazolin-11-one, 6,7,8,9-tetrahydro
|
|
3 | [2058.00; 2064.00] |
| 46-138-8 |
«alpha»-D-Galactopyranose, 1,2,3,4,6-pentakis-O-(trimethylsilyl)-
|
32166-80-6 |
3 | 1894.00 |
| 46-139-7 |
4-Cyclopropyl-6-methyl-N-phenyl-N-trifluoroacetyl-pyrimidin-2-amine
|
|
3 | 1940.00 |
| 46-349-4 |
3«alpha»,6«beta»,7«beta»-Trihydroxy-5«beta»-cholanoic acid, MeTMS
|
|
3 | [3321.00; 3374.00] |
| 46-427-7 |
(.+/-.)-2-Phenylbutyric acid, dimethyl(3,3,3-trifluoropropyl)silyl ester
|
|
3 | 1485.00 |
| 46-541-0 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,6-dimethyl
|
|
3 | 1544.00 |
| 46-580-7 |
5,5-Pentamethylene-2-phenyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 2010.00 |
| 46-896-7 |
5-«alpha»-Pregnan-3-«beta»,15 or 16-diol-20-one, MeTMS
|
|
3 | 2856.00 |
| 47-116-1 |
Pyrazolo[1,5-d][1,2,4]triazin-3-one, 2,6,7,7-tetramethyl
|
|
3 | 1600.00 |
| 47-270-0 |
N2-Cyclopropyl-1,3,5-triazine-2,4,6-triamine N2,N4,N6-tris(trifluoroacetate)
|
|
3 | 1673.00 |
| 47-312-3 |
5-«beta»-Cholanoic acid, 3-«alpha»,4-«beta»,12-«alpha»-trihydroxy, methyl ester, TMS
|
|
3 | 3390.00 |
| 47-494-2 |
24-Nor-3«alpha»,7«alpha»-dihydroxy-5«beta»-cholanoic acid, MeTMS
|
|
3 | 3119.00 |
| 47-524-8 |
2-Butenoic acid, 2-methyl-, 2,3,5,7a-tetrahydro-7-(hydroxymethyl)-1H-pyrrolizin-1-yl ester, [1S-[1«alpha»(Z),7a«alpha»]]-
|
723-78-4 |
3 | [1818.00; 1821.00] |
| 47-555-4 |
5«alpha»-Androstane-3«alpha»,17«beta»-diol,bis-TMS
|
|
3 | [2535.00; 2575.00] |
| 47-803-8 |
N-(1,2-Dimethylpropyl)-N,N'-bis(pentafluoropropionyl)-N'-ethyl-6-methylsulfanyl-1,3,5-triazine-2,4-diamine
|
|
3 | 1789.00 |
| 47-980-2 |
5«alpha»-Androstane-2«beta»,3«alpha»,17«beta»-triol, TMS
|
|
3 | 2737.00 |
| 48-702-9 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-cyclopentyl-phosphorothioamidate
|
|
3 | 1613.00 |
| 48-877-6 |
1,2,3,4,6,7,8,9-Octahydro-pyrido[2,1-b]quinazolin-11-one
|
|
3 | 2059.00 |
| 48-923-4 |
5-Methyl-2H-pyrazole-3-carboxylic acid, 2-isopropenyl hydrazide
|
|
3 | 1804.00 |
| 48-928-9 |
3«beta»,16«alpha»,17«alpha»-Tris(trimethylsiloxy)androst-5-ene
|
25876-85-1 |
3 | 2860.00 |
| 48-988-3 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-methyl-phosphorothioamidate
|
|
3 | 1256.00 |
| 49-434-6 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 9-methyl
|
|
3 | 1615.00 |
| 49-838-8 |
5,5-Pentamethylene-2-phenyl-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 2060.00 |
| 49-879-3 |
2-(4-Allyl-2,6-dimethoxy-phenoxy)-1 -(3,4-dimethoxy-phenyl)-propan-1-ol, TMS
|
|
3 | 2655.00 |
| 49-894-6 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, pentyl ester
|
|
3 | 2608.00 |
| 50-014-0 |
6-Methyl-3,5-heptadien-2-one, PFBO # 2
|
|
3 | 1756.00 |
| 50-097-9 |
allo-Cholanic acid, 7«beta»,12«beta»-dihydroxy, Me-TMS
|
|
3 | 3195.00 |
|
« Previous Results
Next Results »
|